In a press release today, the Paul Ehrlich Institute (PEI) announced that it has approved the first clinical trial of a vaccine against COVID-19 in Germany. It is a ribonucleic acid (RNA) vaccine.
https://www.gelbe-liste.de/nachrichten/corona-impfstoff-klinische-studie